Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.


The efficacy and safety of remoxipride in the treatment of schizophrenia were compared with those of haloperidol in a multicentre double-blind 6-week study which was randomized with a parallel group design and was preceded by a washout period. Eighty-nine consecutively admitted men and women meeting the Research Diagnostic Criteria for schizophrenia in an… (More)


  • Presentations referencing similar topics